MedTrace Logo

Effects of Neo40(TM) With Caffeine on Cycling Time Trial Performance

NCT01710761 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2013-01-23

No results posted yet for this study

Summary

Acute supplementation of Neo40(TM), a nitrate lozenge, will improve cycling performance

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Placebo

Same form factor and flavor as test lozenge but contains no active ingredients

DIETARY_SUPPLEMENT

Nitrate supplement with caffeine

Lozenge consisting of beetroot and 75 mg caffeine

Sponsors & Collaborators

  • Neogenis Laboratories

    collaborator OTHER

  • University of Texas at Austin

    lead OTHER

Principal Investigators

  • Lynne Kammer-Kerwick, MSE, MA · The University of Texas at Austin

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-02-28
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01710761 on ClinicalTrials.gov